Shanghai University of Science and Technology, Shanghai, China.
Changjiang Scholar of Ministry of Education, researcher/PhD supervisor and assistant president of Shanghai University of Science and Technology. He currently serves as vice chairman of the Stress Neurobiology Division of the Chinese Society of Neuroscience, Vice Chairman of the Cognitive Neurobiology Division of the Chinese Society of Neuroscience, standing committee member of Anesthesia and Brain Function Division of the Chinese Society of Neuroscience. He has been supported by National Young Thousand, Natural Science Foundation of China (NSFC) Project, NSFC Outstanding Youth Project, NSFC Major Research Program, NSFC Major Project, and 973 Program of Ministry of Science and Technology. He has published a series of papers in Nature, Neuron, Current Biology, Science Advances and other international academic journals as a corresponding author. He has been awarded the first prize of Chongqing Municipal Scientific and Technological Progress, the second prize of Teaching Achievements of the Chinese Academy of Sciences, and the special prize of Teaching Achievements of Shanghai. Academy of Sciences, and the special prize of Teaching Achievements of Shanghai.
Institute of Neurological Disease, Translational Neuroscience Center, West China Hospital, Sichuan University, Chengdu, China
Academician and Professor Ting-Hua Wang is the Director of Laboratory of Neurological Diseases Research in Translational Neuroscience Center, West China Hospital, Sichuan University, Chengdu, China. He was officially elected as the Academician of the European Academy of Natural Sciences (EANS) in 2023. Currently, Professor Ting-Hua Wang also takes the position of the Vice Chairman of China General Hospital Committee of World Federation of Traditional Chinese Medicine, a member of Standing Committee of Nerve Regeneration and Repair Committee of China Research Hospital, a member of Chinese Anatomical Society, and a member of Nerve Regeneration Professional Committee. He has been conducting clinical, basic and translational research on brain and lung protection, anesthesia mechanism, cell therapy, tumor prevention, pain and cognitive disorders since 1999. He has published more than 168 original papers as corresponding author and edited 20 books published by Science Press. His current research focuses on brain injury, bioinformatics, and narcotic drug network mechanisms.
Health and Biomedical Innovation, Clinical and Health Sciences, University of South Australia, Adelaide, Australia 
Professor Xin-Fu Zhou is a Research Chair in Neuroscience and Professor in School of Pharmacy and Medical Sciences in University of South Australia, Adelaide, Australia. Since graduation with PhD in 1990, he has been working in the field of neurotrophins and their functions in normal and diseases. He has published over 245 referred papers among which 210 original papers and given lectures at over 50 conferences, and acts as associate editor and a founder of Neurotoxicity Research and as an editorial board member for 8 journals. His work has been cited 8500 times with H-index of 51. He has made contributions to neurotrophins and their functions in nerve development and in pathological conditions such as nerve injury, pain, Alzheimer’s disease and major depression. His current research focuses on neurobiology of Alzheimer’s disease, depression and neurotrauma.
Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, China
Professor Tian-Qing Li is a Doctor, Post-doctor of Kunming Institute of Zoology of Chinese Academy of Sciences, Doctoral supervisor of Stowers Institute for Medical Research, and a researcher at the Key Laboratory of Primate Biomedicine of Yunnan Province. He has been given a number of honorary titles such as "Yunling Scholar" and "Chang Jiang Scholar". He is engaged in basic and applied research on primate stem cell and embryo development, and published more than 20 high-quality papers on internationally renowned journals such as Nature, Cell Stem Cell, Cell Reports, Stem Cells Reports, Biomaterials as corresponding author, and has 5 related utility patents. He has participated in 12 major scientific research projects, including the major science and technology project of Yunnan Province, and the key research and development projects of the Ministry of Science and Technology of China.
Molecular Bionics University College London, London, UK
Giuseppe Battaglia is Ph.D. in Physical Chemistry of University of Sheffield, Professor of and Group Leader of Catalan Institution for Research and Advanced Studies (ICREA) and Institute for Bioengineering of Catalonia (IBEC) Barcelona Institute of Science and Technology (BIST), Chair of Molecular Bionics University College London, Membership for Advisory Board Membership for UCL Cancer Domain Steering group and Rosalind Franklin Institute Steering group, Review Panel Membership of EPSRC Peer Review College and Integration of Molecular Components in Functional Macroscopic Systems Review Panel Volkswagen Foundation (Germany). He has received 5 grants (Total to date: €38,080,484) and 7 patents. Updating to June of 2022, Giuseppe’s accomplishments have aggregated up to 293 H-index: 56; H-Index age normalised: 3.47; i-10 index: 111.
Center for Epigenetics and Induced Pluripotent Stem Cells, Kennedy Krieger Institute, Johns Hopkins University, Baltimore, USA
Dr. Visar is Ph.D. in Biochemistry and Molecular Biology from the Oklahoma Health Sciences Center, Post-doctor at the Kennedy Krieger Institute of Johns Hopkins University, CEO and owner of Creatrx, Professor of Neurobiology at Johns Hopkins University, Director of the Center for Epigenetics and Induced Pluripotent Stem Cells at Kennedy Krieger Institute, member of the Sickle Cell Cure Foundation and of International Center for Spinal Cord Injury (ICSCI). Dr. Visar is mainly engaged in the research and development of gene therapy and studies the molecular mechanism after spinal cord injury and is determined to promote the recovery of patients with injured nerve function. His honors include receiving the Oklahoma Chapter for Neuroscience Travel Award in 2002, the Fred and Mary Gray Research Achievement Award in 2003, the International Bio-Iron Award in 2005, and the Leader in Spinal Cord Injury Cure Award in 2014 from the International Center for Spinal Cord Injury.
Magnetic Resonance Research Center, West China Hospital, Sichuan University, Chengdu, China
Dr. Xiao-He Tian, MPhil and Ph.D. from School of Engineering and Materials and School of Biomedical Sciences, University of Sheffield, Post-doctoral research at the Center for Molecular Toxicology, School of Chemistry, University College London, Associate research fellow for Clinical Magnetic Resonance Research Center, West China Hospital. His study focuses on super-resolution imaging of subcellular organelles and the treatment of central nervous system diseases with functional nanocarriers. He presided 2 projects of National Natural Science Foundation of China, 2 projects of Fund of Anhui Province, 10 patents, and 8 times Oral presentation at seminars at home and abroad. He has published a total of more than 140 SCI-included papers (H-index = 27, citations > 2500 ) in famous journals including Science Advantages, Advanced Materials, Chemical Science, Biosensors & Bioelectronic, and Theranostics, and has conducted peer review as a reviewer for many journals such as JACS and ACS Nano.
The National Institute of Molecular Genetics, Milan, Italy
Prof. Loris Rizzello graduated Magna cum Laude in Biotechnology (2008) and received his PhD in Nanotechnology at the Italian Institute of Technology (IIT) (2012). He has been a Newton International Fellow for the Royal Society of London, which supported his research at the University College London (UCL), where he pioneered the use nanoparticles for the treatment of human neuronal-tuberculosis and nervous system immunity. After 5 years at UCL (2013-2018), he received the Marie Skłodowska-Curie Actions Individual Fellowship (MSCA-IF) and he relocated for 2 years (2018-2020) at the Institute for Bioengineering of Catalonia (IBEC), where he learnt how to design artificial organoids to model infection diseases. He has been then awarded with the prestigious ERC-Starting Grant (2020, 1.5 Million), and from October 2020 he is appointed as Associate Professor at the University of Milan, where he is studying the host-pathogens interactions and investigating Pandemic Diseases. From March 2021 he is also Principal Investigator at the National institute of Molecular Genetics (INGM), as leader of the ‘Infection Dynamics Laboratory’ (https://infectiondynamics.unimi.it/), he is member of the Doctorate Program in Biomedicine at the University of Barcelona (UB).
Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Shanghai Fudan University Huashan Hospital, Shanghai, China
Professor Wen-Yuan Wang graduated from the National Key Laboratory of Neurobiology, Shanghai Institute of Life Sciences, Chinese Academy of Sciences in 2005 and obtained his Ph.D. from 2006 to 2007, he was engaged in postdoctoral research at the Salk Institute for Biological Studies in California, USA. 2008-2012 Picower Research Center for Learning and Memory, Department of Brain Cognitive Science, Massachusetts Institute of Technology (MIT); The Howard Hughes Medical Institute (HHMI) is a research scientist. From 2013 to 2014, he served as a research scientist, project leader, and postdoctoral supervisor of Biogen in the United States. He was selected as "High-level Overseas Talent" by the Central Organization Department in 2014, and returned to China full-time in 2015. He is currently working at Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences. He is a research fellow, project leader, director of stem cell platform, and double-hired professor of Shanghai Fudan University Huashan Hospital in China Academy of Sciences. He had more than 20 articles published in international high-level academic journals such as Nature, Nature Neuroscience, Learning and Memory, The Journal of Clinical Investigation, Molecular Psychiatry, The Journal of Clinical Investigation, and Oncogenesis. As the backbone of scientific research, he has presided over and participated in many important national research plans, and has been invited as a project review expert for several national key research and development plans.
Department of Neurology, Affiliated Hospital of Zunyi Medical University, Zunyi, China
Professor Zu-Cai Xu is a Doctor of Chongqing Medical University, Doctoral supervisor of both Zunyi Medical University and Dalian Medical University, and a chief physician at the Department of Neurology, Affiliated Hospital of Zunyi Medical University. He has been given a number of honorary titles such as "Provincial Science and Technology Award" and "Guizhou Province's Hundred Level Innovative Talents". He is engaged in Basic and Clinical Research on Epilepsy, and published more than 30 high-quality papers on internationally renowned journals. He has participated in 13 major scientific research projects, including the National Natural Science Foundation of China, and Guizhou Province Epilepsy Basic and Clinical Research Technology Innovation Talent Team Project.
Editorial Board Members
Mohammed Alhawwas, Ph.D., University of South Australia, Adelaide, Australia
Larisa Bobrovskaya, Ph.D., Clinical and Health Sciences, University of South Australia, Adelaide, Australia
Akshay Bhinge, Ph.D., Living Systems Institute, University of Exeter, Exeter, UK
Song Cao, M.D., Department of Psychiatry and Behavioral Sciences, Northwestern University Feinberg School of Medicine, Chicago, USA
Dong-Xu Chen, M.D.,Department of Anesthesiology, West China Second Hospital of Sichuan University, Chengdu, China
Isaac Bul Deng, Ph.D., Department of Neurology, and Norman Fixel Institute for Neurological Diseases, University of Florida, Gainesville, Florida, USA
Hong-Xin Dong, M.D., Psychiatry and Behavioral Sciences and Neurology, Chicago, US
Sally Kelliny, Ph.D., Department of Pharmacology, Faculty of Pharmacy, Assiut University, Assiut, Egypt
Hua Li, Ph.D., Royal Adelaide Hospital, Adelaide, Australia
Qian Li, M.D., West China Hospital of Sichuan University, Chengdu, China
Fei Liu, M.D., Department of Anesthesiology, West China Hospital of Sichuan University, Chengdu, China
Su Liu, Ph.D., Internal center of spinal cord injury, Johns Hopkins School of Medicine, Baltimore, US
Da-Qin Ma, M.D., Imperial College Westminster Hospital, London, UK
Tommaso Martino, M.D., Neuroscience Department, Policlinico Riuniti of Foggia, Foggia, Italy
Ebrahim Mostafavi, Ph.D., Stanford University School of Medicine, Stanford, USA
Istvan Nagy, M.D., Imperial College London, London, UK
Fang Nan, Ph.D., Singleron Biotechnologies Co., Ltd., Köln, Germany
Koji Nishikawa, M.D., Nippon Medical School, Tokyo, Japan
Dian-San Su, M.D., Renji Hospital Affiliated to Shanghai Jiaotong University, Shanghai, China
Jing Tian, M.D., Heidelberg University, Heidelberg, Germany
Giustino Varrassi, Ph.D., M.D., Paolo Procacci Foundation, Roma, Italy
Chao Xie, M.D., University of Rochester, Rochester, US
Jie Yuan, M.D., Imperial College London, London, UK
Yan Zhang, Ph.D., The School of Biomedical Sciences, The Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China
Jian-Guo Zhou, M.D., Universitätsklinikum Erlangen, Department of Radiation Oncology, Erlangen, Germany
Cheng-Ting Zhang, Ph.D., Living Systems Institute, School of Biosciences, College of Life and Environmental Sciences, University of Exeter, Exeter, UK
John Wiley & Sons, Inc. 
Jiayi Huang received her B.Sc. from Wuhan University of Technology before she finished her Ph.D. in the field of preparation and bioapplications of nanomaterials at Institute of Chemistry, Chinese Academy of Sciences (ICCAS). After two years’ post-doctoral research at Arizona State University and Tulane University, she joined Wiley as a journal publishing manager (JPM). Currently, she is managing a series of scientific journals in health sciences. Her responsibility includes launching open access journals in partnership with Chinese societies.
John Wiley & Sons, Inc.
Mingsong Liu received his B.A. (Hons) from Queen's University in Kingston, Ontario, Canada, with major in Linguistics. He worked as a copywriting intern in Vancouver, Canada, and after graduation he joined Wiley as a Journal Publishing Assistant. At present, he is supporting Journal Publishing Managers in the Health Sciences team and its journal portfolio.